课题基金 / 基金详情

Association of deubiquitin ligase and cell surface molecules regulates the pathophysiology of malignant pleural mesothelioma

Association of deubiquitin ligase and cell surface molecules regulates the pathophysiology of malignant pleural mesothelioma
去泛素连接酶和细胞表面分子的关联调节恶性胸膜间皮瘤的病理生理学
批准号:
24659401
负责人:
MORIMOTO Chikao
金额:
$2.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

MORIMOTO Chikao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Malignant pleural mesothelioma (MPM) is an aggressive malignancy arising from mesothelial lining of pleura. It is generally associated with a history of asbestos exposure and has a very poor prognosis. We found that expression of CD26 upregulates periostin secretion by MPM cells, leading to enhanced MPM cell migratory and invasive activity. CD26 potentiates tumor cell invasion through its interaction with alpha5 beta1 integrin, and CD9 negatively regulates tumor cell invasion by reducing the level of CD26-alpha5 beta1 integrin complex through an inverse correlation between CD9 and CD26 expression. We also showed CD26 associated with somatostatin (SST) receptor 4 and this interaction regulates the growth of MPM cells. Moreover, CD26 is also associated with deubiquitin ligase22 (USP22) which regulated the invasion and metastasis of CD26 positive mesothelioma cells and actually these molecules colocalized in the tissue samples of malignant mesothelioma.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
MERSコロナウイルス感染予防治療剤
MERS冠状病毒感染预防和治疗剂
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: []
通讯作者:
Humanized anti-CD26 mAb Leads to Prophylaxis and Treatment of GVHD in Hu-PBL-NOG Model Mice.
人源化抗 CD26 mAb 可预防和治疗 Hu-PBL-NOG 模型小鼠的 GVHD。
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Hatano R, Morimoto C, et al.]
通讯作者: et al.
DOI: 10.3892/or.2012.2116
发表时间: 2013-01
期刊: Oncology reports
影响因子: 4.2
作者: [Amatya VJ, Takeshima Y, Aoe K, Fujimoto N, Okamoto T, Yamada T, Kishimoto T, Morimoto C, Inai K]
通讯作者: Inai K
抗ヒト化CD26モノクローナル抗体又はその抗原結合性断片
抗人源化CD26单克隆抗体或其抗原结合片段
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: []
通讯作者:
13
    To determine the epigenetic regulatory mechanism of cancer stem cells by cell surface molecules.
    • 批准号:
      22650223
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.12万
    • 财政年份:
      2010
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    Basic research of defining the function of CD26 on human immune system and its clinical application for autoimmune diseases.
    Basic Approach for the Development of Molecular Target Therapy for Autoimmune Diseases and Immune-Mediated Disorders.
    • 批准号:
      17109011
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $71.72万
    • 财政年份:
      2005
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    Basic study of molecular target therapy for autoimmune diseases and immune deficiency diseases based on CD26
    • 批准号:
      15209033
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $26.79万
    • 财政年份:
      2003
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    国内基金
    海外基金
    CD26阳性肿瘤相关成纤维细胞促进乳腺 癌T-DXd耐药的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      邹宇田
    • 依托单位:
    CD26多功能核酸适配体的构建及其在原位成像中的应用研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      王丹丹
    • 依托单位:
    Wnt2/β-catenin调控食管损伤中CD26表达促成纤维细胞转分化的机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      何可心
    • 依托单位:
    TFPI在急性肺损伤中通过CD26/CXCL12/CXCR4信号通路调控间充质干细胞迁移和定植的机制研究
    • 批准号:
      82000087
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      王林林
    • 依托单位: